Ariad Pharmaceuticals Stock Shines on Iclusig (NASDAQ:ARIA)
Cadence Pharmaceuticals Surges On OFIRMEV Update (NASDAQ:CADX)
As the bio pharmaceuticals market is expected to reach $199.7 billion by the end of 2013, we would like for you to observe Cadence Pharmaceuticals stock symbol CADX. Cadence Pharmaceuticals specializes in acquiring, in-licensing, developing and commercializing proprietary products in the bio pharmaceutical market. The Company is currently a surge of +34.86% Up 2.05 with over 7.8 million shares in play at a price per share value of $7.93 November Friday 15, 2013 3:08PM EST. So whatâs hot about the stock you ask?